Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients
Open Access
- 29 August 2008
- journal article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 6 (1), 46
- https://doi.org/10.1186/1479-5876-6-46
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysisBMJ, 2008
- Usefulness of Aspirin Resistance After Percutaneous Coronary Intervention for Acute Myocardial Infarction in Predicting One-Year Major Adverse Coronary EventsThe American Journal of Cardiology, 2006
- Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent PathwayCirculation, 2006
- Improved outcome in central nervous system aspergillosis, using voriconazole treatmentBlood, 2005
- Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarctionThe American Journal of Cardiology, 2005
- Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?American Heart Journal, 2004
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease. Assessment by platelet aggregation testing.Stroke, 1994
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Procedures for Detecting Outlying Observations in SamplesTechnometrics, 1969